Clinical Trial Update: Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE) [Phase 3]

View source ↗

Summary

Phase 3 trial updating the status of the SCD-CARRE study evaluating red cell exchange in sickle cell disease; the trial is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: University of Pittsburgh | Conditions: Sickle Cell Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING